Lipopolysaccharide binding protein: its role and therapeutical potential in inflammation and sepsis.
Schumann
R R
RR
Max-Delbrück-Centrum für Molekulare Medizin (MDC), Berlin, Germany.
Lamping
N
N
Kirschning
C
C
Knopf
H P
HP
Hoess
A
A
Herrmann
F
F
D000209:Acute-Phase Proteins / Q000378:metabolism*; D000818:Animals; D016470:Bacteremia / Q000503:physiopathology* / Q000628:therapy; D001665:Binding Sites; D002352:Carrier Proteins / Q000378:metabolism*; D016905:Gram-Negative Bacterial Infections / Q000503:physiopathology* / Q000628:therapy; D006801:Humans; D007249:Inflammation / Q000503:physiopathology* / Q000628:therapy; D008070:Lipopolysaccharides / Q000378:metabolism*; D008562:Membrane Glycoproteins; D012772:Shock, Septic / Q000503:physiopathology* / Q000628:therapy; D000099231:Lipopolysaccharide-Binding Protein
D000209:Acute-Phase Proteins; D002352:Carrier Proteins; D008070:Lipopolysaccharides; D008562:Membrane Glycoproteins; D000099231:Lipopolysaccharide-Binding Protein